|Day Low/High||35.46 / 36.49|
|52 Wk Low/High||24.21 / 59.25|
Analysts and advisors stand by Nike as NFL.
Several cannabis companies are planning to go public this fall.
Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.
This is simply a short-term thesis that the cannabis rally will cool this week.
Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.
Two companies, PepsiCo and Constellation Brands, are disrupting their own businesses and getting no credit whatsoever for doing so.
Even bullish analysts are cautious on Constellation's big cannabis bet.
Odds are good that you'll make at least 8% in 37 days using this put play.
Odds are good that you'll make at least 8% in 37 days using this play.
Constellation Brand's bigger stake in Canopy has analysts mulling the prospects of a takeover.
With the price of CGC up around 8% this morning a fresh look at the charts is in order.
CGC and STZ should both remain 'go to' plays on the marijuana industry.
China's National Bureau of Statistics released weak July numbers yesterday.
Canopy Growth is getting serious about CBD treatments for your pets.
Let's go through all of our charts and indicators.
Beer companies are going to greater lengths to grow.
New fund will take a more international focus as more countries move toward legalizing cannabis for medical use.
Aurora will use Shopify as its e-commerce engine for medical and recreational cannabis distribution globally.
A historic endorsement of pot legalization by a key wine and beer trade group marks the latest foray by alcohol producers into cannabis.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer interviewed marijuana company Canopy Growth's CEO Bruce Linton.
Several micro-cap and private companies are pulling in millions in capital as they prepare for the start of legal adult marijuana use in Canada.
PE-based backers of Canada-based Tilray come from the realm of smart money.
A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29.
The food and beverages space offers huge potential for those curious about cannabis but who do not want to smoke.
Legalization of cannabis is becoming increasingly likely in Canada and the biggest player is Canopy.
While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.
Canopy Growth's New York Stock Exchange listing does not distract its CEO from the main target: Canada's recreational cannabis market.